---
document_datetime: 2023-09-21 20:07:53
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/alli-epar-all-authorised-presentations_en.pdf
document_name: alli-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0526662
conversion_datetime: 2025-12-27 20:49:35.316439
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| Annex A - alli 60mg Hard Capsules   | Annex A - alli 60mg Hard Capsules   |          |                     |                         | Packaging     |              |
|-------------------------------------|-------------------------------------|----------|---------------------|-------------------------|---------------|--------------|
| EU number                           | Invented name                       | Strength | Pharmaceutical Form | Route of administration |               | Package size |
| EU/1/07/401/007                     | alli                                | 60 mg    | Capsule, hard       | Oral use                | Bottle (HDPE) | 42           |
| EU/1/07/401/008                     | alli                                | 60 mg    | Capsule, hard       | Oral use                | Bottle (HDPE) | 60           |
| EU/1/07/401/009                     | alli                                | 60 mg    | Capsule, hard       | Oral use                | Bottle (HDPE) | 84           |
| EU/1/07/401/010                     | alli                                | 60 mg    | Capsule, hard       | Oral use                | Bottle (HDPE) | 90           |
| EU/1/07/401/011                     | alli                                | 60 mg    | Capsule, hard       | Oral use                | Bottle (HDPE) | 120          |